Lasa Supergenerics Company Description

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India.

It offers API bulk drug products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, triciabendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, halquinol, and 2,6-diiodo-4-nitrophenol; and other API products.

The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide.

In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

Lasa Supergenerics Limited

Country	India
Founded	2016
Industry	Medicinal Chemicals and Botanical Products
Employees	66
CEO	Omkar Herlekar

Contact Details

Address: Plot no. C-4 Ratnagiri, 415722 India
Phone	91 77 9888 8188
Website	lasalabs.com

Stock Details

Ticker Symbol	540702
Exchange	Bombay Stock Exchange
Fiscal Year	April - March
Reporting Currency	INR
SIC Code	2833

Key Executives

Name	Position
Omkar Herlekar	Chief Executive Officer
Varsha Joshi	Chief Financial Officer